1. Home
  2. JVA vs LSTA Comparison

JVA vs LSTA Comparison

Compare JVA & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coffee Holding Co. Inc.

JVA

Coffee Holding Co. Inc.

HOLD

Current Price

$3.72

Market Cap

21.0M

ML Signal

HOLD

Logo Lisata Therapeutics Inc.

LSTA

Lisata Therapeutics Inc.

HOLD

Current Price

$2.05

Market Cap

20.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JVA
LSTA
Founded
1971
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Misc Health and Biotechnology Services
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.0M
20.9M
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
JVA
LSTA
Price
$3.72
$2.05
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$23.50
AVG Volume (30 Days)
41.4K
139.2K
Earning Date
09-12-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
64.91
N/A
EPS
0.32
N/A
Revenue
$89,748,681.00
$1,070,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$11.45
N/A
Revenue Growth
17.92
N/A
52 Week Low
$2.75
$1.81
52 Week High
$9.93
$4.20

Technical Indicators

Market Signals
Indicator
JVA
LSTA
Relative Strength Index (RSI) 42.48 40.79
Support Level $3.32 $1.86
Resistance Level $3.84 $2.13
Average True Range (ATR) 0.25 0.16
MACD 0.01 -0.00
Stochastic Oscillator 45.18 53.76

Price Performance

Historical Comparison
JVA
LSTA

About JVA Coffee Holding Co. Inc.

Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.

Share on Social Networks: